This review provides insights into the role of the IL-33-ST2 signaling pathway in sepsis, asthma, and chronic pulmonary obstructive disease and identifies potential therapeutic targets to provide a more reliable basis for disease treatment than is in the literature (Fig. 1). Here, IL1RL1 is linked to asthma.